medicine2 papersavg year 2026quality 5/5moderate evidence

Clinical Translation and Validation

Research gap analysis derived from 2 medicine papers in our local library.

The gap

There is a need for clinical validation of AI-driven gene therapy designs using patient-derived cell models and animal disease models before human trials.

Consensus across the literature

Most papers highlight the importance of translating laboratory findings into clinical applications, but lack specific validation steps.

Research trend

Emerging — attention growing, methods still coalescing.

Supporting evidence — 2 representative gaps

  • AetherCell: A generative engine for virtual cell perturbation and in vivo drug discovery (2026) · doi

    AetherCell's drug synergy predictions are benchmarked against DrugComb portal data, but systematic comparison of predicted versus experimentally validated synergistic combinations in patient-derived organoids and primary tumor samples is missing. This gap limits clinical translation for personalized combination therapy design.

    Keywords: drug synergy prediction DrugComb patient-derived organoids primary tumors combination therapy personalized medicine
  • Mesenchymal stromal cells in Rheumathology: Recent findings (2026) · doi

    Identification of the most responsive patient populations for MSC therapy is needed to improve clinical efficacy.

    Keywords: identification responsive patient populations therapy needed improve clinical efficacy

Working on this gap? Publish with us.

Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.

Related gaps in medicine

Command palette

Jump anywhere, run any action.